| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.0001 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.36 |
0.0001 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |